Chrysin induces brown fat–like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes

Nutrition

Volumn 32, Issue 9, 2016, Pages 1002-1010

  Choi, Jae Heon ^a   Yun, Jong Won ^a  

^a Daegu University   (South Korea)

Author keywords

Antiobesity; Chrysin; Fat browning; Non shivering thermogenesis; UCP 1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; CARNITINE PALMITOYLTRANSFERASE I; CHRYSIN; DORSOMORPHIN; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR 1 ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; FLAVONOID;

3T3 CELL LINE; 3T3 L1 CELL LINE; ADIPOCYTE; ARTICLE; BROWN ADIPOSE TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; ENZYME INHIBITION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GLYCATION; IMMUNOBLOTTING; IN VITRO STUDY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; METABOLIC REGULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; THERMOGENESIS; UPREGULATION; ADIPOGENESIS; ANIMAL; CELL CULTURE TECHNIQUE; DRUG EFFECTS; METABOLISM; MOUSE; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, BROWN; ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; FLAVONOIDS; LIPID METABOLISM; MICE; POLYMERASE CHAIN REACTION;

EID: 84964597368     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.02.007     Document Type: Article

References (66)

1. [1] Kushner, R.F., Foster, G.D., Obesity and quality of life. Nutrition 16 (2000), 947–952.
2. [2] Gesta, S., Tseng, Y.H., Kahn, C.R., Developmental origin of fat: tracking obesity to its source. Cell 131 (2007), 242–256.
3. [3] Harms, M., Seale, P., Brown and beige fat: development, function and therapeutic potential. Nat Med 19 (2013), 1252–1263.
4. [4] van der Lans, A.A., Hoeks, J., Brans, B., Vijgen, G.H., Visser, M.G., Vosselman, M.J., et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J Clin Invest 123 (2013), 3395–3403.
5. [5] van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M., Drossaerts, J.M., Kemerink, G.J., Bouvy, N.D., et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 360 (2009), 1500–1508.
6. [6] Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 360 (2009), 1518–1525.
7. [7] Lim, S., Honek, J., Xue, Y., Seki, T., Cao, Z., Andersson, P., et al. Cold-induced activation of brown adipose tissue and adipose angiogenesis in mice. Nat Protoc 7 (2012), 606–615.
8. [8] Rosenwald, M., Perdikari, A., Rulicke, T., Wolfrum, C., Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol 15 (2013), 659–667.
9. [9] Bonet, M.L., Oliver, P., Palou, A., Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta 1831 (2013), 969–985.
10. [10] Calvani, R., Leeuwenburgh, C., Marzetti, E., Brown adipose tissue and the cold war against obesity. Diabetes 63 (2014), 3998–4000.
11. [11] Duluc, L., Soleti, R., Clere, N., Andriantsitohaina, R., Simard, G., Mitochondria as potential targets of flavonoids: focus on adipocytes and endothelial cells. Curr Med Chem 19 (2012), 4462–4474.
12. [12] Merlin, J., Evans, B.A., Dehvari, N., Sato, M., Bengtsson, T., Hutchinson, D.S., Could burning fat start with a brite spark? Pharmacological and nutritional ways to promote thermogenesis. Mol Nutr Food Res 60 (2016), 18–42.
13. [13] Sellayah, D., Bharaj, P., Sikder, D., Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab 14 (2011), 478–490.
14. [14] Baboota, R.K., Singh, D.P., Sarma, S.M., Kaur, J., Sandhir, R., Boparai, R.K., et al. Capsaicin induces “brite” phenotype in differentiating 3T3-L1 preadipocytes. PLoS One, 9, 2014, e103093.
15. [15] Zhang, Z., Zhang, H., Li, B., Meng, X., Wang, J., Zhang, Y., et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun, 5, 2014, 5493.
16. [16] Lone, J.B., Choi, J.H., Kim, S.W., Yun, J.W., Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. J Nutr Biochem 27 (2016), 193–202.
17. [17] Yao, L.H., Jiang, Y.M., Shi, J., Tomas-Barberan, F.A., Datta, N., Singanusong, R., et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 59 (2004), 113–122.
18. [18] De Rosa, S., De Stefano, S., Chrysin 7-gentiobioside from the flowers of spartium junceum. Phytochemistry 22 (1983), 2323–2324.
19. [19] Izuta, H., Shimazawa, M., Tazawa, S., Araki, Y., Mishima, S., Hara, H., Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5 Y cells. J Agric Food Chem 56 (2008), 8944–8953.
20. [20] Anandhi, R., Annadurai, T., Anitha, T.S., Muralidharan, A.R., Najmunnisha, K., Nachiappan, V., et al. Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. J Physiol Biochem 69 (2013), 313–323.
21. [21] Kasala, E.R., Bodduluru, L.N., Madana, R.M., V, A.K., Gogoi, R., Barua, C.C., Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol Lett 233 (2015), 214–225.
22. [22] Torres-Piedra, M., Ortiz-Andrade, R., Villalobos-Molina, R., Singh, N., Medina-Franco, J.L., Webster, S.P., et al. A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11 beta-hydroxysteroid dehydrogenase type 1 inhibition. Eur J Med Chem 45 (2010), 2606–2612.
23. [23] Chen, Y.H., Yang, Z.S., Wen, C.C., Chang, Y.S., Wang, B.C., Hsiao, C.A., et al. Evaluation of the structure-activity relationship of flavonoids as antioxidants and toxicants of zebrafish larvae. Food Chem 134 (2012), 717–724.
24. [24] Gresa-Arribas, N., Serratosa, J., Saura, J., Sola, C., Inhibition of CCAAT/enhancer binding protein delta expression by chrysin in microglial cells results in antiinflammatory and neuroprotective effects. J Neurochem 115 (2010), 526–536.
25. [25] Wu, N.L., Fang, J.Y., Chen, M., Wu, C.J., Huang, C.C., Hung, C.F., Chrysin protects epidermal keratinocytes from UVA- and UVB-induced damage. J Agric Food Chem 59 (2011), 8391–8400.
26. [26] Pushpavalli, G., Veeramani, C., Pugalendi, K.V., Influence of chrysin on hepatic marker enzymes and lipid profile against D-galactosamine-induced hepatotoxicity rats. Food Chem Toxicol 48 (2010), 1654–1659.
27. [27] Zeng, W., Yan, Y., Zhang, F., Zhang, C., Liang, W., Chrysin promotes osteogenic differentiation via ERK/MAPK activation. Protein Cell 4 (2013), 539–547.
28. [28] El-Bassossy, H.M., Abo-Warda, S.M., Fahmy, A., Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation. Am J Chin Med 42 (2014), 1153–1167.
29. [29] Ali, B.H., Adham, S.A., Al Za'abi, M., Waly, M.I., Yasin, J., Nemmar, A., et al. Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats. PLoS One, 10, 2015, e0125285.
30. [30] Li, X., Huang, Q., Ong, C.N., Yang, X.F., Shen, H.M., Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett 293 (2010), 109–116.
31. [31] Ismail, T.A., Soliman, M.M., Nassa, M.A., Mohamed, D.I., Antihypercholesterolemic effects of mushroom, chrysin, curcumin and omega-3 in experimental hypercholesterolemic rats. J Food Nutr Res 3 (2015), 77–87.
32. [32] Zarzecki, M.S., Araujo, S.M., Bortolotto, V.C., de Paula, M.T., Jesse, C.R., Prigol, M., Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57 BL/6 mice. Toxicol Rep 1 (2014), 200–208.
33. [33] Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983), 55–63.
34. [34] Gonzalez-Castejon, M., Rodriguez-Casado, A., Dietary phytochemicals and their potential effects on obesity: a review. Pharmacol Res 64 (2011), 438–455.
35. [35] Sergent, T., Vanderstraeten, J., Winand, J., Beguin, P., Schneider, Y.J., Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem 135 (2012), 68–73.
36. [36] Badimon, L., Vilahur, G., Padro, T., Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther 28 (2010), 202–215.
37. [37] Nakajima, V.M., Macedo, G.A., Macedo, J.A., Citrus bioactive phenolics: role in the obesity treatment. Lebensm Wiss Technol 59 (2014), 1205–1212.
38. [38] Choo, J.J., Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem 14 (2003), 671–676.
39. [39] Klaus, S., Pultz, S., Thone-Reineke, C., Wolfram, S., Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes 29 (2005), 615–623.
40. [40] Sharp, L.Z., Shinoda, K., Ohno, H., Scheel, D.W., Tomoda, E., Ruiz, L., et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One, 7, 2012, e49452.
41. [41] Tiraby, C., Tavernier, G., Lefort, C., Larrouy, D., Bouillaud, F., Ricquier, D., et al. Acquirement of brown fat cell features by human white adipocytes. J Biol Chem 278 (2003), 33370–33376.
42. [42] Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26 (2012), 271–281.
43. [43] Seale, P., Conroe, H.M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121 (2011), 96–105.
44. [44] Hardie, D.G., AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 32 (2008), S7–S12.
45. [45] Luo, Z., Saha, A.K., Xiang, X., Ruderman, N.B., AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26 (2005), 69–76.
46. [46] Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006), 2256–2264.
47. [47] Wang, S., Liang, X., Yang, Q., Fu, X., Rogers, C.J., Zhu, M., et al. Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK)α1. Int J Obes 39 (2015), 967–976.
48. [48] Rachid, T.L., Penna-de-Carvalho, A., Bringhenti, I., Aguila, M.B., Mandarim-de-Lacerda, C.A., Souza-Mello, V., Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice. Mol Cell Endocrinol 402 (2015), 86–94.
49. [49] Ahn, J., Lee, H., Kim, S., Park, J., Ha, T., The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373 (2008), 545–549.
50. [50] Ono, M., Fujimori, K., Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J Agric Food Chem 59 (2011), 13346–13352.
51. [51] Sell, H., Berger, J.P., Samson, P., Castriota, G., Lalonde, J., Deshaies, Y., et al. Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinol 145 (2004), 3925–3934.
52. [52] Tai, T.A., Jennermann, C., Brown, K.K., Oliver, B.B., MacGinnitie, M.A., Wilkison, W.O., et al. Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J Biol Chem 271 (1996), 29909–29914.
53. [53] Vernochet, C., Peres, S.B., Davis, K.E., McDonald, M.E., Qiang, L., Wang, H., et al. C/EBPα and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol 29 (2009), 4714–4728.
54. [54] Ohno, H., Shinoda, K., Spiegelman, B.M., Kajimura, S., PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15 (2012), 395–404.
55. [55] Roberts, L.D., Murray, A.J., Menassa, D., Ashmore, T., Nicholls, A.W., Griffin, J.L., The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol, 12, 2011, R75.
56. [56] Harada, K., Shen, W.J., Patel, S., Natu, V., Wang, J., Osuga, J., et al. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am J Physiol Endocrinol Metab 285 (2003), E1182–E1195.
57. [57] Rosen, E.D., Hsu, C.H., Wang, X., Sakai, S., Freeman, M.W., Gonzalez, F.J., et al. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev 16 (2002), 22–26.
58. [58] Elberg, G., Gimble, J.M., Tsai, S.Y., Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. J Biol Chem 275 (2000), 27815–27822.
59. [59] Mottagui-Tabar, S., Ryden, M., Lofgren, P., Faulds, G., Hoffstedt, J., Brookes, A.J., et al. Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia 46 (2003), 789–797.
60. [60] Sekiya, M., Osuga, J., Okazaki, H., Yahagi, N., Harada, K., Shen, W.J., et al. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep ob/ob mice. J Biol Chem 279 (2004), 15084–15090.
61. [61] Strom, K., Hansson, O., Lucas, S., Nevsten, P., Fernandez, C., Klint, C., et al. Attainment of brown adipocyte features in white adipocytes of hormone-sensitive lipase null mice. PLoS One, 3, 2008, e1793.
62. [62] Holm, C., Østerlund, T., Laurell, H., Contreras, J.A., Molecular mechanisms regulating hormone-sensitive lipase. Annu Rev Nutr 20 (2000), 365–393.
63. [63] Kraemer, F.B., Shen, W.J., Hormone-sensitive lipase: control of intracellular tri-(di-) acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 43 (2002), 1585–1594.
64. [64] Miyoshi, H., Souza, S.C., Endo, M., Sawada, T., Perfield, J.W. 2nd, Shimizu, C., et al. Perilipin overexpression in mice protects against diet-induced obesity. J Lipid Res 51 (2010), 975–982.
65. [65] Sawada, T., Miyoshi, H., Shimada, K., Suzuki, A., Okamatsu-Ogura, Y., Perfield, J.W. 2nd, et al. Perilipin overexpression in white adipose tissue induces a brown fat-like phenotype. PLoS One, 5, 2010, e14006.
66. [66] Sztalryd, C., Xu, G., Dorward, H., Tansey, J.T., Contreras, J.A., Kimmel, A.R., et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 161 (2003), 1093–1103.